Evaluation of notifiable infectious diseases between 2018 and 2021 in Van province: A descriptive study

Yıl 2023, Cilt: 14 Sayı: 48, 39 - 44, 30.04.2023

Ömer Faruk Tekin Müberra Çakıcı Tosun

https://doi.org/10.17944/interdiscip.1285744

Öz

Objective: In this study, it was aimed to examine the infectious diseases reported in Van province between 2018 and 2021 in terms of various characteristics.

Method: It is a descriptive study that was conducted between January 1 and January 31, 2022. Necessary permissions and an ethics committee were obtained for the study. Infectious diseases reported in Van province between January 1, 2018 and September 30, 2021 were examined using the Infectious Diseases Surveillance and Early Warning System (IZCI) of the Ministry of Health. It was examined in terms of various variables. The study’s data were analysed with the Jamovi 2.2 statistical program. Descriptive data were given as numbers and percentages. The Pearson Chi-square test was used for comparisons between categorical variables.

Results: There were 16778 notifications between 01.01.2018-30.09.2021. Of the people with the reported disease, 59.5% were men and 40.5% were women. The mean age was 23.3±19.0 (min: 0-max: 99). The 3 most frequently reported diseases/conditions were 32.51% (n=5455) Brucellosis, 31.07% (n=5212) Rabies-risk contact, and 12.70% (n=2131) Rotavirus. There were 5555 (33.1%) disease reports in 2018, 4769 (28.4%) in 2019, 3411 (20.3%) in 2020, and 3043 (18.1%) in the first nine months of 2021. The incidence of Brucellosis, Rabies Risky Contact, Echinococcosis, and Anthrax diseases was found to be higher in rural districts than in urban districts (for each p<0.001).

Conclusion: The most common infectious diseases reported in the city where the study was conducted were Brucellosis, Rabies Risky Contact, and Rotavirus disease, respectively. The fact that the main livelihood of Van province is animal husbandry may explain the prevalence of zoonotic diseases.

Anahtar Kelimeler

Notification, Infectious Disease, Surveillance

Kaynakça

• Tulchinsky T, Varavikova E. Bulaşıcı Hastalıklar. In: Vaizoğlu S (eds). Yeni Halk Sağlığı. 3. Baskı. Ankara: Palme Yayınevi; 2019. pp. 149–233.
• Gibbons CL, Mangen M-JJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014;14(1):147. https://doi.org/10.1186/1471-2458-14-147.
• Swaan C, van den Broek A, Kretzschmar M, Richardus JH. Timeliness of notification systems for infectious diseases: A systematic literature review. PLoS One. 2018;13(6):e0198845. https://doi.org/10.1371/journal.pone.0198845.
• Keramarou M, Evans MR. Completeness of infectious disease notification in the United Kingdom: A systematic review. J Infect. 2012;64(6):555–64. https://doi.org/10.1016/j.jinf.2012.03.005.
• Keskinler ÜD. The Evaluation of Obligatory Notificable Diseases Reported In Provincial Health Directorate In Erzurum. Journal of Turgut Ozal Medical Center. 2003;10(2):77–81.
• Public Health Law. 06.05.1930; Number: 1489 [Internet]. [cited 2022 Apr 21]. Available from: https://www.resmigazete.gov.tr/arsiv/1489.pdf.
• Communique on the Notification System of Infectious Diseases. 06.11.2004; Number: 25635 [Internet]. [cited 2022 Apr 12]. Available from: https://www.mevzuat.gov.tr/atNo=8580&MevzuatTur=9&MevzuatTertip=5.
• Notification System of Infectious Diseases. Circular 2015/18 [Internet]. [cited 2022 Apr 12]. Available from: https://hsgm.saglik.gov.tr/dosya/mevzuat/genelge/2015_18.pdf.
• Wurtz R, Cameron BJ. Electronic Laboratory Reporting for the Infectious Diseases Physician and Clinical Microbiologist. Clin Infect Dis. 2005;40(11):1638–43. https://doi.org/10.1086/429904.
• Turkish Statistical Institute (TÜİK). [cited 2022 Apr 12]. Available from: https://data.tuik.gov.tr/Kategori/GetKategori?p=Nufus-ve-Demografi-109.
• İbrhim İE, Uçku R. Assessment of Communicable Disease Notification in a University Hospital, 2005-2008. DEÜ Tıp Fakültesi Derg. 2012;26(1):1–7.
• Kıymet E, Böncüoğlu E, Çağlar İ, Zora F, Apa H, Bayram N, et al. Evaluation of Infectious Diseases Surveillance Data in 2018 in Dr. Behcet Uz Children’s Hospital. J Dr Behcet Uz Child s Hosp. 2019;9(3):223-228. https://doi.org/10.5222/buchd.2019.13471.
• Geng M-J, Zhang H-Y, Yu L-J, Lv C-L, Wang T, Che T-L, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021;12(1):6923. https://doi.org/10.1038/s41467-021-27292-7.
• Adegbija O, Walker J, Smoll N, Khan A, Graham J, Khandaker G. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Commun Dis Intell. 2021;45.
• Neiderud C-J. How urbanization affects the epidemiology of emerging infectious diseases. Infect Ecol Epidemiol. 2015;5(1):27060. https://doi.org/10.3402/iee.v5.27060.
• Connolly C, Keil R, Ali SH. Extended urbanisation and the spatialities of infectious disease: Demographic change, infrastructure and governance. Urban Stud. 2021;58(2):245–63. https://doi.org/10.1177/0042098020910873.